Earthquake survivor from Kendal climbs 446 mountains
The journey saw him travel to Bristol and through the Brecon Beacons and North Wales, before reaching the Peak District, the Yorkshire Dales, Northumberland and the Lakes.Mr Staniforth told BBC Radio Cumbria it was a "relief to be done" and that he was "enjoying the fact I don't have to run or bike anywhere today"."Having a night at home in my own bed was quite a luxury. It's not really sunk in."It was a goal I'd had for years and years, but it had often felt impossible."The last few days were so wild and wet, but then on Helvellyn it changed to the perfect afternoon. Sharing that last peak with people there was a very special moment."It might be a while before anyone is daft enough to try to go quicker."
In the UK, a mountain is generally considered to be a summit of more than 2,000ft (600m), according to the Ordnance Survey.In all, Mr Staniforth said he ascended almost 10 times the height of Mount Everest.Working as a motivational speaker, he launched the Mind Over Mountains charity having dealt with anxiety and depression since he was a teenager.It uses nature walks and outdoor activities to support people with mental health issues."Being outside has helped me manage it," he said."It's not a cure or a magic pill, but it's a tool other people could benefit from."So many people are suffering with their mental health and the biggest cause of death in under-35s is suicide."We've had lots of support over the last few days and every pound makes an impact."
Follow BBC Cumbria on X, Facebook, Nextdoor and Instagram.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
27 minutes ago
- The Independent
Pupils with special needs ‘have to travel further to school for suitable place'
Children with special educational needs are having to travel long distances to school due to a lack of suitable provision near home, councils have suggested. Budgets for home to school transport are under 'considerable pressure' as many special schools are full, which is forcing pupils to travel further, according to a Local Government Association (LGA) report. Spending by councils on transporting children and young people with special educational needs and disabilities (Send) to schools is predicted to reach around £1.97 billion in 2025/26, up from around £1.73 billion in 2023/24 and approximately £645 million in 2015/16. Children under eight are entitled to free home to school transport if the nearest suitable school is more than two miles away, or more than three miles for older children. The average one-way trip to school for pupils with Send is nine miles, according to the research carried out by the Isos Partnership, but one county council reported an average distance of 22.8 miles. Councils reported that a 'growing minority' of children and young people with Send are travelling very long distances to school – often due to a lack of suitable special school places closer to their home. The report warned that continuing to fulfil the current statutory responsibilities for home to school transport is becoming 'increasingly financially unsustainable' for local authorities. The findings have been published during the LGA's three-day annual conference in Liverpool this week. Schools minister Catherine McKinnell is due to address council leaders on the Send system at the LGA's conference on Wednesday morning. Department for Education (DfE) data last week showed that the number of education, health and care plans (EHCPs) – which set out the support a young person requires for their Send needs – has increased. In total, there were 638,745 EHCPs in place in January, up 10.8% on the same point last year. The LGA report said the rise in the number of children and young people who require education in a special setting has 'placed considerable pressure on home to school transport budgets as most special schools are full, forcing children to travel further distances to access a place that meets their needs'. Councils have reported a 40% rise over the last five years in children and young people with Send (aged under 16) needing home to school transport, the research suggested. Arooj Shah, who chairs the LGA's children and young people board, said: 'The rapidly rising need for home to school transport from children and young people in Send is yet another reminder of the huge pressures on the Send system. 'It is also wrong that children are increasingly having to travel long distances to get to school because of a lack of provision near to their home. 'This has to change. 'We urge the Government in its White Paper to deliver the comprehensive reforms the Send system needs, so that it is more inclusive and improves educational attainment for children. 'This should also include putting councils on a stable financial footing by writing off councils' high needs deficits, which are projected to reach £5 billion next year.' A DfE spokeswoman said: 'This Government inherited a Send system left on its knees – which is why we are looking at changes to enable more children to thrive in mainstream settings and stop parents having to fight for help, while bringing about financial sustainability for councils. 'Through our plan for change, we're already making progress by investing £740 million to create more places for children with Send in mainstream schools, as well as increasing early access to speech, language and neurodiversity support to prevent needs from escalating. 'This will pave the way for significant, long-term reform – improving children's and parents' experiences and addressing the pressures councils are facing, including around home to school transport.'
The Independent
an hour ago
- The Independent
Terminal breast cancer patients denied life-extending drugs
Thousands of women battling advanced breast cancer could be denied access to crucial life-extending medication due to an "unfair" assessment process for NHS drug approval. Charity Breast Cancer Now has issued an urgent plea to Health Secretary Wes Streeting, demanding "immediate action" to dismantle current spending restraints. The organisation is also calling for the NHS spending watchdog, the National Institute for Health and Care Excellence (Nice), to lower its threshold for what it classifies as a "very severe health condition." Nice's severity modifier, introduced in 2022, is designed to give greater weight to treatments for more severe illnesses, increasing the likelihood of their recommendation for NHS use. However, Breast Cancer Now argues that the current criteria are too stringent, potentially preventing thousands of women from accessing vital therapies. According to Nice, the process raises the threshold for what it considers to be a cost-effective treatment, meaning it can give more expensive drugs the green light. However, a new report from Breast Cancer Now claims the system means women with incurable breast cancer with months to live may be told their condition does not qualify for the most severe rating. The call comes after it emerged that the life-extending drug Enhertu will not be made available for women with incurable breast cancer on the NHS in England and Wales. In November, Nice said talks with manufacturers AstraZeneca and Daiichi Sankyo over the price of the medication had broken down for the third time with no agreement. Claire Rowney, chief executive at Breast Cancer Now, said: 'The terrifying reality is that unless urgent action is taken thousands of women in the UK with incurable secondary breast cancer could be denied access to vital life-extending treatments because of an unfair system. 'We're talking about patients missing out on access to cutting-edge, effective treatments that could give them more time to be there for special moments such as birthdays or seeing their children or grandchildren start school. 'Treatments, such as Enhertu, that patients in other countries, including Scotland, can access, giving them the chance to live longer. 'Women with secondary breast cancer tell us they feel their lives are being deprioritised by the changes to the system. 'We will not stand by and witness more drugs being rejected or not taken forward, when the devastating cost is thousands more people with secondary breast cancer across England, Wales and Northern Ireland having their lives cut short.' Paula Van Santen, 50, was diagnosed with secondary breast cancer in July 2022, two months after her diagnosis of primary breast cancer. The mother-of-three, from Banbury in Oxfordshire, said: 'Secondary breast cancer has changed the lives of both myself and my family beyond belief. Coming to terms with my diagnosis is the hardest part because I've had to grieve for the life I had, but also the life that I'm not going to have. 'If a new drug can give me another six months, if it gives me another year, it's worth it. 'It could allow me to see my daughter get to 21, see my children get married or meet grandchildren. Just to have a picture with a grandchild so they would know that I existed would be so precious. That's what this could give.' Main symptoms of breast cancer in women NHS Ms Rowney called for 'change' and said Mr Streeting should scrap 'opportunity-cost neutral' restraints. Opportunity cost neutrality in the Nice severity modifier aims to ensure the new system does not require more or less overall NHS funding than the old one. According to the Breast Cancer Now report, this is 'at the root of the issues with the modifier'. It added: 'It pits end-of-life cancer treatments against other severe conditions like cystic fibrosis in a way that's reductive and unfair to patients. And, ultimately, it creates barriers to the approval of drugs for advanced cancers.' Ms Rowney said: 'The system for deciding whether drugs are approved for use on the NHS must change now. 'We're calling for immediate action from Wes Streeting, Secretary of State for Health and Social Care, to urgently scrap 'opportunity-cost neutral' restraints and for Nice to lower the bar for what it defines as 'a severe condition'. And we stand ready to work with them.' Dr Samantha Roberts, chief executive of Nice, welcomed the report from Breast Cancer Now, saying: 'The independent analysis we commissioned recently showed the new severity weighting is working as intended and expected. 'It is able to be applied more widely – for example to treatments for cystic fibrosis, hepatitis D and Duchenne muscular dystrophy – and has contributed to an increase in positive decisions for cancer medicines and non-cancer medicines. 'And other breast cancer treatments have been recommended since we introduced the severity modifier – including for advanced breast cancer. 'We remain deeply disappointed that we were unable to recommend Enhertu for HER2-low advanced breast cancer. We know this was devastating to all those hoping for a different answer. 'It remains the only breast cancer treatment we have been unable to recommend in seven years.' A Department of Health and Social Care spokesperson said the upcoming 10-year health plan will 'transform the NHS and improve care for those facing cancer'. 'This includes rolling out DIY screening kits for cervical cancer, more radiotherapy machines in every region and opening more Community Diagnostic Centres closer to where people live,' they added. 'We know how disappointing it is to many families that the manufacturers of Enhertu are unwilling to sell this life-extending treatment to the NHS at a fair and reasonable price. Our door remains open to supporting the introduction of medicines at a cost-effective price.'
The Independent
an hour ago
- The Independent
Almost one in five NHS operations now carried out in private hospitals
Nearly one in five NHS operations are now being carried out in private hospitals or clinics, new analysis reveals. Data from the Independent Healthcare Providers Network (IHPN) revealed that private facilities delivered the equivalent of 2,859 NHS procedures every working day in April. The figure is an increase of over 60 per cent compared to the same month in 2019, and a record high. Overall, the independent sector is delivering 10 per cent of all NHS planned care, up from eight per cent before the Covid-19 pandemic. The IHPN also said that the number of referrals it had received also reached a new high, with private providers receiving 7,162 referrals each working day in April. Meanwhile, official NHS data show that the waiting list for routine hospital treatment in England has fallen to its lowest level for two years. An estimated 7.39 million treatments were waiting to be carried out at the end of April, relating to 6.23 million patients, down from 7.42 million treatments and 6.25 million patients at the end of March. The government has set out plans to send more patients for treatment in private hospitals to slash waiting lists. David Hare, chief executive of the IHPN, said that this latest data 'shows the independent sector's increasingly pivotal role in delivering frontline NHS care'. He said private hospitals delivering record levels of NHS care will be 'instrumental in helping the government to meet their key milestone to ensure 92 per cent of patients are treated within 18 weeks by the end of this Parliament'. 'While this is a clear sign of welcome progress in tackling NHS waiting lists, the sector is committed to building on this already impressive achievement and will be working with the Government to ensure the principles contained in the recent NHS and Independent Sector Partnership Agreement are fully embedded – enabling patients to have a greater choice over their care so they can get the treatment they need, when they need it.'
